九安医疗
(002432)
| 流通市值：160.85亿 | | | 总市值：170.74亿 |
| 流通股本：4.47亿 | | | 总股本：4.74亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,296,129,069.33 | 3,506,427,371.98 | 2,887,657,440.16 | 1,763,704,310.03 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 衍生金融资产 | - | - | - | 0 |
| 应收票据及应收账款 | 80,426,754.42 | 56,967,621.97 | 107,876,222.69 | 219,311,158.77 |
| 其中：应收票据 | 815,047.45 | 42,216.8 | 184,014.1 | 1,814,460.94 |
| 应收账款 | 79,611,706.97 | 56,925,405.17 | 107,692,208.59 | 217,496,697.83 |
| 应收款项融资 | - | - | - | 0 |
| 预付款项 | 73,873,026.88 | 56,264,676.7 | 58,667,970.7 | 31,401,157.78 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 103,286,874.51 | 82,708,107.73 | 64,673,049.2 | 90,187,468.27 |
| 其中:应收利息 | 56,944,671.87 | 45,140,548.86 | 36,908,974.53 | 68,067,430.4 |
| 应收股利 | 0 | 2,659,908.63 | - | 0 |
| 买入返售金融资产 | - | - | - | 0 |
| 存货 | 157,560,156.84 | 219,997,860.32 | 217,641,285.47 | 211,805,424.27 |
| 合同资产 | - | - | - | 0 |
| 一年内到期的非流动资产 | 3,619,926,713.89 | 3,183,208,715.61 | 3,070,478,953.71 | 388,509,584.13 |
| 其他流动资产 | 22,893,959.42 | 25,678,731.28 | 40,532,438.26 | 54,157,328.51 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 14,276,093,278.68 | 14,077,286,222.89 | 14,094,178,779.27 | 11,435,867,719.72 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | - | 0 |
| 债权投资 | 1,595,780,164.24 | 2,361,387,974.4 | 2,268,359,349.01 | 4,978,983,906.1 |
| 其他债权投资 | - | - | - | 0 |
| 长期应收款 | - | - | - | 0 |
| 长期股权投资 | 0 | 0 | 4,874,153.3 | 5,061,216 |
| 其他权益工具投资 | 924,909,320.6 | 650,820,448.91 | 413,333,192 | 306,399,526.56 |
| 其他非流动金融资产 | 9,173,136,586.25 | 8,534,954,308.77 | 7,025,515,111.43 | 6,528,576,300.66 |
| 投资性房地产 | - | - | - | 0 |
| 固定资产 | 332,175,009.96 | 335,115,388.03 | 326,149,207.66 | 336,402,105.09 |
| 在建工程 | 44,065,647.01 | 9,489,261.16 | 8,288,576.32 | 3,946,021.08 |
| 生产性生物资产 | - | - | - | 0 |
| 油气资产 | - | - | - | 0 |
| 使用权资产 | 35,662,735 | 46,877,161.12 | 19,070,351.41 | 23,737,503.18 |
| 无形资产 | 63,071,473.97 | 67,876,305.37 | 73,052,481.18 | 79,051,987.32 |
| 开发支出 | 9,355,476.18 | 9,086,581.93 | 8,644,300.68 | 8,464,974.19 |
| 商誉 | - | - | - | 0 |
| 长期待摊费用 | 10,965,584.06 | 12,115,267.85 | 10,839,105.04 | 9,242,837.52 |
| 递延所得税资产 | 104,528,989.48 | 105,185,234.11 | 63,120,863.03 | 63,136,766.28 |
| 其他非流动资产 | 95,782,277.78 | 125,158,221.22 | 149,094,792.74 | 169,356,761.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 12,389,433,264.53 | 12,258,066,152.87 | 10,370,341,483.8 | 12,512,359,905.12 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 26,665,526,543.21 | 26,335,352,375.76 | 24,464,520,263.07 | 23,948,227,624.84 |
| 流动负债: | | | | |
| 短期借款 | 1,770,459,490.02 | 1,431,748,734.45 | 1,260,000,000 | 1,350,000,000 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | - | - | - | 0 |
| 衍生金融负债 | - | - | - | 0 |
| 应付票据及应付账款 | 51,046,713.3 | 80,171,420.18 | 69,729,172.59 | 84,218,917.06 |
| 其中：应付票据 | - | - | - | 0 |
| 应付账款 | 51,046,713.3 | 80,171,420.18 | 69,729,172.59 | 84,218,917.06 |
| 预收款项 | - | - | - | 0 |
| 合同负债 | 67,051,516.56 | 153,829,122.69 | 38,607,586.53 | 33,971,651.16 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 43,767,641.28 | 73,804,963.46 | 58,105,798.45 | 31,250,743.66 |
| 应交税费 | 58,008,575.58 | 78,993,256.12 | 50,080,326.18 | 18,328,312.27 |
| 其他应付款合计 | 15,233,372.71 | 14,615,869.55 | 6,539,426.98 | 9,119,216.78 |
| 其中:应付利息 | 505,666.67 | 0 | - | - |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | 1,230,631,673.82 | 726,613,261.13 | 295,987,703.59 | 178,930,582.46 |
| 其他流动负债 | 259,833.81 | 308,017.6 | 690,184.85 | 493,140.98 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,236,458,817.08 | 2,560,084,645.18 | 1,779,740,199.17 | 1,706,312,564.37 |
| 非流动负债: | | | | |
| 长期借款 | 613,000,000 | 1,177,000,000 | 1,597,000,000 | 1,778,000,000 |
| 应付债券 | - | - | - | 0 |
| 租赁负债 | 21,966,565.92 | 24,328,458.84 | 12,684,709.24 | 14,804,297.39 |
| 长期应付款 | - | - | - | 0 |
| 长期应付职工薪酬 | - | - | - | 0 |
| 预计负债 | - | - | - | 0 |
| 递延收益 | 10,303,921.43 | 11,105,281.63 | 10,964,448.68 | 11,760,749.5 |
| 递延所得税负债 | 1,093,183,386.25 | 1,072,216,772.52 | 1,042,590,586.71 | 984,993,342.32 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,738,453,873.6 | 2,284,650,512.99 | 2,663,239,744.63 | 2,789,558,389.21 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,974,912,690.68 | 4,844,735,158.17 | 4,442,979,943.8 | 4,495,870,953.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 473,144,232 | 492,796,670 | 490,621,332 | 490,307,069 |
| 其他权益工具 | - | 0 | - | 0 |
| 资本公积 | 1,512,497,889.67 | 1,922,008,951.69 | 2,114,494,646.58 | 2,088,488,399.11 |
| 减:库存股 | 1,094,834,198.9 | 1,704,073,414.25 | 2,286,268,307.62 | 2,286,268,307.62 |
| 其他综合收益 | 1,918,811,674.31 | 1,679,772,786.15 | 870,190,404.09 | 1,154,644,539.5 |
| 专项储备 | - | - | - | 0 |
| 盈余公积 | 194,242,507.29 | 194,242,507.29 | 189,910,161.1 | 189,910,161.1 |
| 一般风险准备 | - | - | - | 0 |
| 未分配利润 | 18,418,038,296.51 | 18,151,756,042.88 | 17,893,949,377.75 | 17,127,067,178.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 21,421,900,400.88 | 20,736,503,543.76 | 19,272,897,613.9 | 18,764,149,039.67 |
| 少数股东权益 | 268,713,451.65 | 754,113,673.83 | 748,642,705.37 | 688,207,631.59 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 21,690,613,852.53 | 21,490,617,217.59 | 20,021,540,319.27 | 19,452,356,671.26 |
| 负债和股东权益合计 | 26,665,526,543.21 | 26,335,352,375.76 | 24,464,520,263.07 | 23,948,227,624.84 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |